SCHEMBL8932357

SCHEMBL8932357

CN1CCC[C@@H]1Cc1c[nH]c2ccc(OCCCl)cc12

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 7/20 0.76
HTR1A P08908 2/20 0.76
HTR6 P50406 9/20 0.72
HTR1D P28221 5/20 0.67
GABRP O00591 2/20 0.55
GABRD O14764 2/20 0.55
GABRA1 P14867 2/20 0.55
GABRB1 P18505 2/20 0.55
GABRG2 P18507 2/20 0.55
GABRB3 P28472 2/20 0.55
GABRA5 P31644 2/20 0.55
GABRA3 P34903 2/20 0.55
GABRA2 P47869 2/20 0.55
GABRB2 P47870 2/20 0.55
GABRA4 P48169 2/20 0.55
GABRE P78334 2/20 0.55
GABRA6 Q16445 2/20 0.55
GABRG1 Q8N1C3 2/20 0.55
GABRG3 Q99928 2/20 0.55
GABRQ Q9UN88 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8932358 1.00 HTR1B (0.76) HTR1BHTR1AHTR6HTR1DGABRP
SCHEMBL8879855 0.89 HTR1B (0.72) HTR1BHTR1AHTR6HTR1DGABRP
SCHEMBL8808971 0.88 HTR1B (0.70) HTR1BHTR1AHTR6HTR1D
SCHEMBL8617260 0.88 HTR1B (0.70) HTR1BHTR1AHTR6HTR1D
SCHEMBL5819875 0.86 HTR1B (1.00) HTR1BHTR1AHTR6HTR1D
SCHEMBL5819877 0.86 HTR1B (1.00) HTR1BHTR1AHTR6HTR1D
SCHEMBL8790464 0.86 HTR1B (1.00) HTR1BHTR1AHTR6HTR1D
SCHEMBL1388908 0.85 HTR1B (0.67) HTR1BHTR1AHTR6HTR1D
SCHEMBL8615007 0.85 HTR1B (0.67) HTR1BHTR1AHTR6HTR1DGABRP
SCHEMBL1388907 0.85 HTR1B (0.67) HTR1BHTR1AHTR6HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996026936-A1 NOVEL CYCLIC AMINO-INDOLE PIPERAZINE DERIVATIVES, PREPARATION PROCESS AND UTILIZATION AS MEDICAMENTS PIERRE FABRE MEDICAMENT (FR) 1996-09-06 WO disclosed